In the current study, we found that IL-6 blockade enhanced Ang1 production by tumor cells, whereas siRNA-induced Ang1 depletion restored the impaired anti-angiogenic function of Bev under IL-6 blockade. Here, ANGPT1 is linked to neoplasm.